A mechanically powered negative pressure device used in conjunction with a bioengineered cell-based product for the treatment of pyoderma gangrenosum: A case report

Ostomy Wound Management

Volumn 58, Issue 9, 2012, Pages 44-48

  Neiderer, Katherine ^a,b   Martin, Billy ^a   Hoffman, Steven ^a   Jolley, David ^a   Dancho, James ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

artificial skin; case report; negative pressure wound therapy; pyoderma gangrenosum; wounds

Indexed keywords

AGED; BIOENGINEERING; CASE REPORT; CONFERENCE PAPER; HUMAN; MALE; PYODERMA GANGRENOSUM;

AGED; BIOENGINEERING; HUMANS; MALE; PYODERMA GANGRENOSUM;

EID: 84866487647     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Binus AM, Qureshi AA, Li VW, Winterfeld LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244-1250.
2. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB, Jr., White WL, Callen J P. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore). 2000;79(1):37-46. (Pubitemid 30077735)
3. Su W P, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gan-grenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790-800. (Pubitemid 39529936)
4. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ. 2006;333(7560):181-184. (Pubitemid 44406745)
5. Ghersi MM, Ricotti C, Nousari CH, Newman MI. Negative pressure dressing in the management of pyoderma gangrenosum ulcer. Arch Der-matol. 2007;143(10):1249-1251. (Pubitemid 47607692)
6. Alam M, Grossman ME, Schneiderman PI, Blume RS, Benvenisty AI. Surgical management of pyoderma gangrenosum: case report and review. Dermatol Surg. 2000;26(11):1063-1066.
7. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38(6):563-576.
8. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704-1710. (Pubitemid 41587449)
9. Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multi-center randomized controlled trial. Diabetes Care. 2008;31(4):631-636.
10. Vuerstaek JD, Vainas T, Wuite J, Nelemans P, Neumann MH, Veraart JC. State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg. 2006;44(5):1029-1037. (Pubitemid 46107242)
11. Schneider AM, Morykwas MJ, Argenta LC. A new and reliable method of securing skin grafts to the diffcult recipient bed. Plast Reconstr Surg. 1998;102(4):1195-1198. (Pubitemid 28414653)
12. Genecov DG, Schneider AM, Morykwas MJ, Parker D, White WL, Argenta LC. A controlled subatmospheric pressure dressing increases the rate of skin graft donor site reepithelialization. Am Plast Surg. 1998;40(3):219-225. (Pubitemid 28106901)
13. Morykwas MJ, Simpson J, Punger K, Argenta A, Kremers L, Argenta J. Vacuum-assisted closure: sate of basic research and physiologic function. Plast Reconstr Surg. 2006;117(7 suppl):121S-126S. (Pubitemid 44317776)
14. Armstrong DG, Marston WA, Reyzelman AM, Kirsner RS. Comparative effectiveness of mechanically and electrically powered negative pressure wound therapy devices: A multicenter randomized controlled trial. Wound Repair Regen. 2012;20(3):332-341.
15. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(2):290-295. (Pubitemid 32119127)
16. Briscoe DM, Dharnidharka VR, Isaacs C, et al. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection. Transplantation. 1999;67(12):1590-1599. (Pubitemid 29315682)
17. Falanga V, Margolis D, Alvarez O, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol. 1998;134(3):293-300. (Pubitemid 28141616)
18. Su W P, Schroeter AL, Perry HO, Powell FC. Histopathologic and im-munopathologic study of pyoderma gangrenosum. J Cutan Pathol. 1986;13(5):323-330. (Pubitemid 16009117)
19. White DJ. FK506: the promise and the paradox. Clin Exp Immunol. 1991;83(1):1-3.
20. LeCleach L, Moguelet P. Perrin P, Chosidow O. Is topical monother-pay effective for localized pyoderma granrenosum? Arch Dermatol. 2011;147(1):101-103.
21. Wollina U, Haroske G. Pyoderma gangraenosum. Curr Opin Rheumatol. 2011;23(1):50-56.
22. Duchini G, Itin P, Arnold A. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents. Adv Skin Wound Care. 2011;24(5):217-220.
23. de Imus G, Golomb C, Wilkel C, Tsoukas M, Nowak M, Falanga V. Accelerated healing of pyoderma gangrenosum treated with bioengi-neered skin and concomitant immunosuppression. J Am Acad Dermatol. 2001;44(1):61-66. (Pubitemid 32110563)
24. Geller SM, Longton JA. Ulceration of pyoderma gangrenosum treated with negative pressure wound therapy. J Am Podiatr Med Assoc. 2005;95(2):171-174. (Pubitemid 40515339)